98%
921
2 minutes
20
Background: Few studies have evaluated the association between short-term PM exposure and children's respiratory mortality. This study examines the relationship between daily mean and maximum 1-hour PM exposures and age-specific pediatric respiratory mortality, addressing a gap in understanding the effects of subdaily PM peaks.
Methods: We analyzed ICD-10-coded mortality records (n = 90,566) from the Mexico City Metropolitan Area (2004-2019). PM exposures came from our satellite-based models for daily mean and maximum 1-hour concentrations. Using a time-stratified case-crossover design and conditional logistic regression with distributed lags, we examined associations between PM and nonaccidental mortality, and specific respiratory conditions (e.g., influenza, pneumonia, bronchopulmonary dysplasia) across neonates, infants, children, and adolescents, accounting for sex-based effect modification. Our models included negative control exposures to address potential confounding.
Results: Among all age groups, infants were the most affected by daily mean and maximum 1-hour PM concentrations. Mean PM was associated with higher risk of respiratory, and influenza and pneumonia mortality in infants. In the same age group, an increase of 10 μg/m in the maximum 1-hour PM concentration was associated with nonaccidental (odds ratio [OR][lag] = 1.02 [95% confidence interval {CI}: 1.00, 1.03]), respiratory (OR[lag] = 1.04 [95% CI: 1.02, 1.06]), influenza and pneumonia (OR[lag] = 1.05 [95% CI: 1.02, 1.08]), and bronchopulmonary dysplasia-related (OR[lag] = 1.07 [95% CI: 1.00, 1.15]) mortality. Our results suggest effect modification by sex in the association between mean PM and respiratory mortality, with positive associations observed primarily in male neonates and adolescents.
Conclusions: Our study contributes to the evidence on the association between daily PM exposure and pediatric respiratory mortality, while also revealing new insights into the impact of maximum 1-hour PM on age- and cause-specific respiratory mortality.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12200233 | PMC |
http://dx.doi.org/10.1097/EE9.0000000000000408 | DOI Listing |
World J Gastroenterol
August 2025
Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Dusit 10300, Bangkok, Thailand.
Background: Hepatocellular carcinoma (HCC) is a major health concern in Thailand, with most patients diagnosed at the intermediate stage. Transarterial chemoembolization (TACE) is the standard treatment; however, postembolization syndrome (PES) remains a common complication. Although both dexamethasone (DEXA) and N-acetylcysteine (NAC) have shown efficacy in reducing PES, no study has directly compared their effects.
View Article and Find Full Text PDFBMJ Paediatr Open
September 2025
Department of Neonatology, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Objective: To assess the activity of the diaphragm using electromyography (dEMG) prior and during apnoea-induced intermittent hypoxaemia (IH) events in preterm infants DESIGN: A single-centre observational study.
Setting: Neonatal intensive care unit.
Patients: Preterm infants (<32 weeks of gestation) experiencing IH events with a frequency of >1/hour METHODS: Heart rate, oxygen saturation (SpO) and dEMG were measured for 24 hours.
Chem
April 2025
Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Combinatorial peptidomimetic libraries facilitate the economical identification and refinement of lead compounds directed at diverse therapeutic targets. Further development of selection-based approaches to drug discovery utilizing such libraries is impeded, however, both by the slow pace of library generation and by the physical limitations to library diversity inherent to current methods. To overcome these barriers, we describe here the adaptation of peptide flow synthesis technology to the generation of combinatorial libraries.
View Article and Find Full Text PDFJAMA Netw Open
August 2025
Division of Pulmonary, Critical Care & Sleep Medicine, Department of Medicine, University of Washington and Harborview Medical Center, Seattle.
Importance: Phenobarbital monotherapy is increasingly used to treat alcohol withdrawal syndrome (AWS) in hospitalized patients, but its implementation outside academic emergency departments (EDs) and intensive care units (ICUs) remains understudied.
Objective: To evaluate the implementation, clinical outcomes, and safety of an electronic health record (EHR) order set for intravenous weight-based phenobarbital loading (10 or 15 mg/kg) across all care locations (ED, acute care, and ICU) of a community hospital.
Design, Setting, And Participants: This retrospective quality improvement study was conducted at a 281-bed community hospital in Seattle, Washington, including all hospitalized adults treated for AWS 11 months before and 12 months after implementation of the phenobarbital EHR order set (April 1, 2021, to March 31, 2023).
Clin Pharmacol Drug Dev
August 2025
National Drug Clinical Trial Institution of West China Second Hospital, Sichuan University, Chengdu, China.
This randomized, open-label, 2-period crossover study evaluated food effects on SPH3348 pharmacokinetics (PK) and safety in 16 healthy participants receiving a single 480-mg dose under fasting and high-fat fed conditions. PK profiling involved serial blood sampling at 15 predefined time points per period, while safety assessments included continuous monitoring of adverse events throughout the study. PK analysis revealed pronounced food-dependent alterations.
View Article and Find Full Text PDF